Allen Duplantier, PhD
Principal investigator
Dr. Allen Duplantier is a medicinal chemist with 20 years of industry and 8 years of government experience in drug discovery and development. He has worked in all stages of early drug development including hit-to-lead, lead optimization, candidate selection and IND submission, and has a proven track record in delivering clinical candidates in multiple therapeutic areas. He has been a project leader across chemistry, biology, DMPK, toxicology and pharmaceutical sciences, and has a strong capability of designing drugs that provide adequate unbound drug levels in target tissue. He has years of direct interaction and collaboration with funding agencies, military labs, big pharma and numerous small biotechs and universities. He is an effective science and technology manager of large and broad portfolio of projects and a successful manager of external chemistry, ADME and pharmacokinetic resources through CROs. He is a multidisciplinary collaborator and mentor.
Dr. Duplantier received a Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology, and a B.S. in Chemistry from the University of New Orleans.
More team members
Andrew Fradkin, JD
Walter Greenblatt, MBA
Mike McGinnis, MS, MBA
Anne Moscona, MD
Ruth Karron, MD
Matteo Porotto, PhD
Elma Hawkins, PhD, MBA
Fred Hayden, MD
Joan Fusco, PhD
Tom Monath, MD
Sean Whelan, PhD
Daniel Graifman, MBA
